Suzuken is a Japanese pharmaceutical company founded in 1932 and headquartered in Nagoya. It operates through four main segments: Pharmaceutical Wholesale, which focuses on the sale of pharmaceuticals, diagnostic drugs, and medical equipment; Pharmaceutical Manufacturing, which produces these drugs and diagnostics; Insurance Pharmacy, which dispenses medications based on prescriptions; and Medical-related Services, which includes the sale of medical literature, nursing services, and the production of physiological examination equipment. With a comprehensive approach that spans research, development, and support for pharmaceutical manufacturers, Suzuken has established itself as a unique entity in the medical field.
Frontier Field is a venture company that brings the medical and healthcare fields together with the power of IT. It also engaged in the planning, development, sales, and maintenance of the nibyo mobile smartphone exclusively for medical institutions.
Oishi Kenko
Series C in 2022
Oishi Kenko Inc., founded in 2016 and headquartered in Tokyo, Japan, focuses on promoting health through food. The company publishes films that emphasize cooking, the wisdom of living, and the significance of maintaining a healthy mind. Additionally, Oishi Kenko provides a recipe search and menu creation service, which is supervised by registered dietitians, aimed at preventing and managing diseases while supporting dietary needs. By integrating culinary arts with health awareness, Oishi Kenko seeks to make healthy eating both enjoyable and accessible.
Ubie
Series C in 2022
Ubie, Inc. is a Tokyo-based company founded in 2017 that specializes in developing artificial intelligence-driven healthcare solutions. Its primary product is an AI symptom checker, designed to aid hospitals and physicians by delivering individualized evaluation reports based on patient responses to a brief questionnaire. The system tailors its questions according to various factors, including biological sex, age, medical history, and lifestyle choices. By providing a patient summary and predictive diagnosis, Ubie's technology enhances the diagnostic process, facilitating more personalized care for patients.
DOCTORS
Series B in 2021
Doctors offer a healthcare platform that provides digital health services. They offer development support, distribution support, sales support, medical cooperation-type online medical support, digital health services, planning and development, marketing, and environmental support.
Embrace Japan
Acquisition in 2021
Embrace Co., Ltd. is a Tokyo-based company that specializes in the development of a medical caring station platform designed to enhance medical treatment and information sharing among hospitals, clinics, nursing facilities, and drugstores. Founded in 2003, the company aims to facilitate communication within an integrated community care system, allowing medical professionals to exchange real-time information. This capability supports the optimization of medical care, treatment, and prevention activities, ultimately improving patient outcomes. Embrace's approach combines expertise from various fields, including IT and pharmaceuticals, to address significant challenges in the medical care sector.
DOCTORS
Venture Round in 2020
Doctors offer a healthcare platform that provides digital health services. They offer development support, distribution support, sales support, medical cooperation-type online medical support, digital health services, planning and development, marketing, and environmental support.
Stella Pharma
Corporate Round in 2020
Stella Pharma Corporation, founded in 2007 and based in Osaka, Japan, specializes in the development and marketing of boron-based pharmaceuticals, particularly for use in boron neutron capture therapy (BNCT). This innovative form of cancer treatment utilizes boron compounds to target and destroy cancer cells effectively. As a subsidiary of Stella Chemifa Corporation, Stella Pharma is dedicated to advancing medical care through its research and development efforts in therapeutic drugs, aiming to improve patient outcomes in oncology.
Ubie
Series B in 2020
Ubie, Inc. is a Tokyo-based company founded in 2017 that specializes in developing artificial intelligence-driven healthcare solutions. Its primary product is an AI symptom checker, designed to aid hospitals and physicians by delivering individualized evaluation reports based on patient responses to a brief questionnaire. The system tailors its questions according to various factors, including biological sex, age, medical history, and lifestyle choices. By providing a patient summary and predictive diagnosis, Ubie's technology enhances the diagnostic process, facilitating more personalized care for patients.
Susmed
Venture Round in 2020
Susmed is a software company focused on developing therapeutic applications and clinical trial systems, utilizing blockchain technology to enhance their offerings. The company specializes in creating medical equipment and software systems that facilitate the collection and distribution of medical information. By integrating innovative technology into healthcare, Susmed aims to improve the efficiency and effectiveness of clinical trials and therapeutic solutions.
Embrace Japan
Venture Round in 2020
Embrace Co., Ltd. is a Tokyo-based company that specializes in the development of a medical caring station platform designed to enhance medical treatment and information sharing among hospitals, clinics, nursing facilities, and drugstores. Founded in 2003, the company aims to facilitate communication within an integrated community care system, allowing medical professionals to exchange real-time information. This capability supports the optimization of medical care, treatment, and prevention activities, ultimately improving patient outcomes. Embrace's approach combines expertise from various fields, including IT and pharmaceuticals, to address significant challenges in the medical care sector.
Dr.JOY
Corporate Round in 2019
Dr.JOY is a hospital social networking service focused on enhancing the efficiency of medical institutions by streamlining workflows. The platform is designed to alleviate the excessive burden on healthcare professionals while providing essential information to patient families at medical facilities globally. It offers a range of features that support hospital operations, including attendance management, beacon automatic stamping, and collaboration among in-hospital, regional, and pharmaceutical entities. Additionally, Dr.JOY provides services for searching drugs and side effects, thereby enabling healthcare organizations to operate more effectively and improve patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.